NYSE$ATR
AptarGroup Inc. · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
AptarGroup reported solid Q3 2022 results, with net income increasing by 15% and core sales growing by 9% despite a challenging economic backdrop.
AptarGroup's Q3 2022 results showed a 15% increase in net income to $54 million, with core sales up 9%. The Pharma segment drove growth with double-digit core sales increases, while Beauty + Home faced supply chain issues in North America. The company expects continued growth in Pharma but anticipates softening demand in personal care, food, and beverage markets.
- Reported sales grew 1% and net income increased 15% to $54 million.
- Core sales increased 9% and adjusted EBITDA was even with the prior year level of $154 million.
- Reported earnings per share increased 16% to $0.81 compared to $0.70 in the prior year.
- Adjusted earnings per share increased 12% to $0.95 compared to $0.85 in the prior year.
Headline financials
Revenue & EPS history
AptarGroup · Revenue · Quarterly
$837M
Revenue by segment
AptarGroup · $837M total across 3 segments · Q3 2022
- Beauty$360M-3.8%43.0%
- Pharma$343M+9.6%41.0%
- Closures$134M-3.2%16.0%
Forward guidance
Aptar expects Q4 2022 earnings per share to be in the range of $0.73 to $0.83, excluding restructuring expenses, changes in the fair value of equity investments and acquisition costs. This guidance is based on an effective tax rate range of 28% to 30% and a Euro/US$ exchange rate of 0.98.
Headwinds
- Pharma segment is expected to grow at more normalized levels.
- Do not expect to repeat last year’s strong sales of active material solutions for at-home COVID-19 test kits.
- Anticipate the softening in demand in markets such as personal care, food and beverage to continue.
- Managing the inflationary environment through price initiatives and energy surcharges, as well as controlling expenses.
- Continue to allocate capital selectively while maintaining our strong balance sheet.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
+0.3%
Avg return
Earnings day
-0.1%
Avg return
5 days after
+1.2%
Avg return
30 days after
63%
43 / 68 earnings
Positive
+9.2%
Q4 2017
Best reaction
-9.0%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | -0.8% | -6.4% | |
| Q4 2025 | +8.3% | +12.9% | +6.5% | |
| Q3 2025 | -9.0% | -7.1% | +0.3% | |
| Q1 2025 | +2.3% | +2.1% | +6.8% | |
| Q4 2024 | -8.5% | -9.4% | -2.3% | |
| Q3 2024 | +0.8% | +0.6% | +2.3% | |
| Q2 2024 | +1.7% | +1.1% | +4.4% | |
| Q1 2024 | +2.4% | +3.1% | +5.8% | |
| Q4 2023 | +5.4% | +3.1% | +8.6% | |
| Q3 2023 | +0.1% | -0.9% | +4.2% | |
| Q2 2023 | +3.2% | +2.1% | +6.3% | |
| Q1 2023 | +2.4% | +4.1% | -1.4% | |
| Q4 2022 | +5.7% | +4.2% | +0.3% | |
| Q3 2022 | +2.1% | -1.9% | +6.9% | |
| Q2 2022 | +1.6% | +0.5% | -1.5% | |
| Q1 2022 | +3.4% | +2.5% | -2.0% | |
| Q4 2021 | +3.3% | +3.8% | +2.7% | |
| Q3 2021 | -3.6% | +1.7% | +1.0% | |
| Q2 2021 | -6.3% | -6.6% | -2.3% | |
| Q1 2021 | -0.2% | +2.6% | -2.5% | |
| Q4 2020 | -7.7% | -10.4% | -2.7% | |
| Q3 2020 | +1.6% | +6.4% | +13.3% | |
| Q2 2020 | -3.0% | -0.2% | -0.6% | |
| Q1 2020 | -3.6% | -4.1% | +1.2% | |
| Q4 2019 | -2.6% | -7.0% | -19.6% | |
| Q3 2019 | -7.1% | -8.9% | -6.0% | |
| Q2 2019 | -5.0% | -5.4% | -1.3% | |
| Q1 2019 | +1.3% | +2.3% | +2.0% | |
| Q4 2018 | +1.5% | +0.0% | +2.2% | |
| Q3 2018 | +1.8% | +2.1% | +2.0% | |
| Q2 2018 | +8.6% | +8.1% | +9.6% | |
| Q1 2018 | +0.3% | +0.4% | +1.0% | |
| Q4 2017 | +9.2% | +11.8% | +9.6% | |
| Q3 2017 | -0.6% | -1.6% | -2.5% | |
| Q2 2017 | -6.5% | -6.3% | -6.4% | |
| Q1 2017 | +1.2% | +1.1% | +6.3% | |
| Q4 2016 | +1.7% | +0.4% | +4.4% | |
| Q3 2016 | -4.3% | -7.4% | -0.3% | |
| Q2 2016 | -1.9% | -3.9% | -1.6% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | +2.4% | — | — | |
| Q2 2015 | +8.3% | — | — | |
| Q1 2015 | +2.4% | — | — | |
| Q4 2014 | +1.8% | — | — | |
| Q3 2014 | +2.0% | — | — | |
| Q2 2014 | -3.5% | — | — | |
| Q1 2014 | -0.1% | — | — | |
| Q4 2013 | +1.9% | — | — | |
| Q3 2013 | +0.2% | — | — | |
| Q2 2013 | -2.1% | — | — | |
| Q1 2013 | -2.0% | — | — | |
| Q4 2012 | -0.8% | — | — | |
| Q3 2012 | -3.5% | — | — | |
| Q2 2012 | +2.6% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q3 2011 | +5.8% | — | — | |
| Q2 2011 | -5.0% | — | — | |
| Q1 2010 | +2.2% | — | — | |
| Q1 2011 | +2.3% | — | — | |
| Q4 2008 | +1.5% | — | — | |
| Q4 2010 | +1.5% | — | — | |
| Q3 2010 | +2.9% | — | — | |
| Q3 2009 | +2.9% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q2 2009 | +0.5% | — | — | |
| Q2 2010 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro